Literature DB >> 11676498

Butyrate-induced differentiation of Caco-2 cells is mediated by vitamin D receptor.

T Gaschott1, O Werz, A Steinmeyer, D Steinhilber, J Stein.   

Abstract

Butyrate in combination with 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] produces a synergistic effect on cell differentiation of human colon cancer cells (Caco-2). The objective of this study was to confirm the role of the vitamin D receptor (VDR) in butyrate-induced cell differentiation of Caco-2. We studied the effects of the novel VDR antagonist ZK 191732 on butyrate-induced cell differentiation and on p21Waf1/Cip1 expression. Butyrate induced cell differentiation which was further enhanced after addition of 1,25-(OH)2D3. Experiments using ZK 191732 indicate that the synergistic effect of butyrate and 1,25-(OH)2D3 was due to butyrate-induced upregulation of VDR. While butyrate alone increased expression of p21Waf1/Cip1 and combined exposure of butyrate and 1,25-(OH)2D3 resulted in a synergistic amplification, p21Waf1/Cip1 expression did not change from the control level after treatment with butyrate plus ZK 191732. These data further imply that butyrate-induced differentiation and p21Waf1/Cip1 expression of Caco-2 cells occur via upregulation of VDR. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676498     DOI: 10.1006/bbrc.2001.5832

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Upregulation of 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase by butyrate in Caco-2 cells.

Authors:  Oliver Schröder; Sinan Turak; Carolin Daniel; Tanja Gaschott; Jürgen Stein
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 2.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

Review 3.  Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.

Authors:  Larissa S Celiberto; Franziska A Graef; Genelle R Healey; Else S Bosman; Kevan Jacobson; Laura M Sly; Bruce A Vallance
Journal:  Immunology       Date:  2018-05-16       Impact factor: 7.397

4.  Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine.

Authors:  Shaoping Wu; Anne P Liao; Yinglin Xia; Yan Chun Li; Jian-Dong Li; R Balfour Sartor; Jun Sun
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

5.  Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study.

Authors:  Chiara Montanari; Camilla Ceccarani; Antonio Corsello; Juri Zuvadelli; Emerenziana Ottaviano; Michele Dei Cas; Giuseppe Banderali; Gianvincenzo Zuccotti; Elisa Borghi; Elvira Verduci
Journal:  Nutrients       Date:  2022-04-29       Impact factor: 6.706

Review 6.  Using components of the vitamin D pathway to prevent and treat colon cancer.

Authors:  Renee E Stubbins; Aisha Hakeem; Nomelí P Núñez
Journal:  Nutr Rev       Date:  2012-10-12       Impact factor: 7.110

7.  The dietary histone deacetylase inhibitor sulforaphane induces human beta-defensin-2 in intestinal epithelial cells.

Authors:  Markus Schwab; Veerle Reynders; Stefan Loitsch; Dieter Steinhilber; Oliver Schröder; Jürgen Stein
Journal:  Immunology       Date:  2008-03-27       Impact factor: 7.397

8.  Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.

Authors:  Magdalena Milczarek; Beata Filip-Psurska; Wiesław Swiętnicki; Andrzej Kutner; Joanna Wietrzyk
Journal:  Oncol Rep       Date:  2014-06-11       Impact factor: 3.906

9.  Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages.

Authors:  A L Millard; P M Mertes; D Ittelet; F Villard; P Jeannesson; J Bernard
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

10.  Impact of vitamin D metabolism on clinical epigenetics.

Authors:  Heidrun Karlic; Franz Varga
Journal:  Clin Epigenetics       Date:  2011-02-08       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.